Purpose: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with chemoradiation or radiation therapy are of limited quality. In this work, we developed a predictive model of survival at 2 years. The model is based on a large volume of historical patient data and serves as a proof of concept to demonstrate the distributed learning approach. Methods and Materials: Clinical data from 698 lung cancer patients, treated with curative intent with chemoradiation or radiation therapy alone, were collected and stored at 2 different cancer institutes (559 patients at Maastro clinic (Netherlands) and 139 at Michigan university [ United States]). The model was further validated on 196 patients originating from The Chri...
This paper focuses on the task of survival time analysis for lung cancer. Although much progress has...
Abstract Background Statistical learning (SL) techniques can address non-linear relationships and sm...
IntroductionAccurate prognosis assessment after non–small-cell lung cancer (NSCLC) diagnosis is an e...
Purpose: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with ...
Purpose Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with ...
PURPOSE\nOne of the major hurdles in enabling personalized medicine is obtaining sufficient patient ...
Purpose: Although patients with stage III non-small cell lung cancer (NSCLC) are homogeneous accordi...
PurposeAlthough patients with stage III non-small cell lung cancer (NSCLC) are homogeneous according...
AbstractPurposeOne of the major hurdles in enabling personalized medicine is obtaining sufficient pa...
Purpose: Classic statistical and machine learning models such as support vector machines (SVMs) can ...
Although patients with stage III non-small cell lung cancer (NSCLC) are homogeneous according to the...
Background and purpose: Predicting outcomes is challenging in rare cancers. Single-institutional dat...
Cancer is the leading cause of death in Taiwan, according to the Ministry of Health and Welfare (201...
BackgroundSurveillance is universally recommended for non-small cell lung cancer (NSCLC) patients tr...
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
This paper focuses on the task of survival time analysis for lung cancer. Although much progress has...
Abstract Background Statistical learning (SL) techniques can address non-linear relationships and sm...
IntroductionAccurate prognosis assessment after non–small-cell lung cancer (NSCLC) diagnosis is an e...
Purpose: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with ...
Purpose Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with ...
PURPOSE\nOne of the major hurdles in enabling personalized medicine is obtaining sufficient patient ...
Purpose: Although patients with stage III non-small cell lung cancer (NSCLC) are homogeneous accordi...
PurposeAlthough patients with stage III non-small cell lung cancer (NSCLC) are homogeneous according...
AbstractPurposeOne of the major hurdles in enabling personalized medicine is obtaining sufficient pa...
Purpose: Classic statistical and machine learning models such as support vector machines (SVMs) can ...
Although patients with stage III non-small cell lung cancer (NSCLC) are homogeneous according to the...
Background and purpose: Predicting outcomes is challenging in rare cancers. Single-institutional dat...
Cancer is the leading cause of death in Taiwan, according to the Ministry of Health and Welfare (201...
BackgroundSurveillance is universally recommended for non-small cell lung cancer (NSCLC) patients tr...
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
This paper focuses on the task of survival time analysis for lung cancer. Although much progress has...
Abstract Background Statistical learning (SL) techniques can address non-linear relationships and sm...
IntroductionAccurate prognosis assessment after non–small-cell lung cancer (NSCLC) diagnosis is an e...